Last week we introduced the subject of the intellectual property position relating to the future phenomenon that is renal denervation. If you recall, this is a technology-based therapy that seems to work by inducing electrophysiological changes into the heart which result in a lowering of blood pressure, even in patients for whom other therapies have not been successful.
We are drawn to return to the subject by the publication of a second piece on the website www.whatisrenaldenervation.com, which can be found here. In it, the discussion pertains to the cause and effect of the procedure and the potential claim of a University in Oklahoma which seems to have quietly placed its own stake in the heart over a dozen years ago.
Interesting stuff.
published: December 19, 2012 in: Cardio, Healthcare, Medtronic, St Jude, Technology